Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Johanna Schreiber

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Cancers|March 28, 2026
Integrating Targeted Therapies into AML Frontline Therapy: Who Gets What and What Does the Future Hold?Johanna Schreiber, Georg Hopfinger, Karoline V Gleixner
Macromolecular Rapid Communications|November 29, 2024
Cyclooctyne End-Functionalized Poly(morpholine-2,5-dione)sJohanna Schreiber, Natalie E Göppert, Leanne M Stafast, et al.
The Journal of Biological Chemistry|October 1, 2008
Deciphering the ligand-binding sites in the Borrelia burgdorferi complement regulator-acquiring surface protein 2 required for interactions with the human immune regulators factor H and factor H-like protein 1Corinna Siegel, Johanna Schreiber, Katrin Haupt, et al.
Advanced Healthcare Materials|November 22, 2025
Evaluating the Antiviral Efficacy of Encapsulated PKC Inhibitor BIM-I against influenza A Virus InfectionLaura Klement, Jana Ismail, Josefine Schroeder, et al.
Wiener Klinische Wochenschrift|February 16, 2022
SARS-CoV-2-related mortality and treatment delays for cancer patients in Austria : Findings of a multicentric nationwide studyJulia M Berger, Phillipp Wohlfarth, Oliver Königsbrügge, et al.
Nature Chemistry|May 20, 2025
A framework for evaluating the chemical knowledge and reasoning abilities of large language models against the expertise of chemistsAdrian Mirza, Nawaf Alampara, Sreekanth Kunchapu, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Cancers|March 28, 2026
Integrating Targeted Therapies into AML Frontline Therapy: Who Gets What and What Does the Future Hold?Johanna Schreiber, Georg Hopfinger, Karoline V Gleixner
Macromolecular Rapid Communications|November 29, 2024
Cyclooctyne End-Functionalized Poly(morpholine-2,5-dione)sJohanna Schreiber, Natalie E Göppert, Leanne M Stafast, et al.
The Journal of Biological Chemistry|October 1, 2008
Deciphering the ligand-binding sites in the Borrelia burgdorferi complement regulator-acquiring surface protein 2 required for interactions with the human immune regulators factor H and factor H-like protein 1Corinna Siegel, Johanna Schreiber, Katrin Haupt, et al.
Advanced Healthcare Materials|November 22, 2025
Evaluating the Antiviral Efficacy of Encapsulated PKC Inhibitor BIM-I against influenza A Virus InfectionLaura Klement, Jana Ismail, Josefine Schroeder, et al.
Wiener Klinische Wochenschrift|February 16, 2022
SARS-CoV-2-related mortality and treatment delays for cancer patients in Austria : Findings of a multicentric nationwide studyJulia M Berger, Phillipp Wohlfarth, Oliver Königsbrügge, et al.
Nature Chemistry|May 20, 2025
A framework for evaluating the chemical knowledge and reasoning abilities of large language models against the expertise of chemistsAdrian Mirza, Nawaf Alampara, Sreekanth Kunchapu, et al.
Pageof 1